The diversity of <i>SNCA</i> transcripts in neurons, and its impact on antisense oligonucleotide therapeutics
James R. Evans(The Francis Crick Institute), Sonia Gandhi(The Francis Crick Institute), John Hardy(UK Dementia Research Institute), Wendy Heywood(Great Ormond Street Hospital), Michele Vendruscolo(University of Cambridge), Gurvir S. Virdi(The Francis Crick Institute), Mina Ryten(Guy's Hospital), David Murphy(National Hospital for Neurology and Neurosurgery), Christina E. Toomey(University College London), Kevin Mills(Great Ormond Street Hospital), Ivan Doykov(Great Ormond Street Hospital), Mhd Hussein Murtada(University of Cambridge), Nicholas Wood(National Hospital for Neurology and Neurosurgery), Hannah Macpherson(University College London), Anna I. Wernick(The Francis Crick Institute), Emil K. Gustavsson(University of British Columbia), Dilan Athauda(University College Lahore), Chun Wei Pang(University College London), Alexander Röntgen(University of Cambridge), Minee L. Choi(Korea Advanced Institute of Science and Technology), Joanne Lachica(University College London)
Cited by 9
Related Papers
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
|Nature Genetics|2009|3.4k
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
|Nature Genetics|2019|2.5k
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
|Nature Genetics|2011|2.1k